Fundraising Fox
Kimialys
4 known investors
Find your way into Kimialys
Sign up to see every warm intro you have to Kimialys
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kimialys team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kimialys provides antibody selection and kinetic characterization services using proprietary Surface Plasmon Resonance imaging (SPRi) technology and K-One surface chemistry for researchers and diagnostics developers. The platform enables rapid identification of optimal antibody candidates for diagnostic assays and therapeutic development across multiple assay formats.
Investors · 4
In the news
Frequently asked questions
- What does Kimialys do?
- Kimialys provides antibody selection and kinetic characterization services using proprietary Surface Plasmon Resonance imaging (SPRi) technology and K-One surface chemistry for researchers and diagnostics developers. The platform enables rapid identification of optimal antibody candidates for diagnostic assays and therapeutic development across multiple assay formats.
- Who are Kimialys's investors?
- Kimialys's investors include Angels Santé, Octalfa, Super Capital VC, Turenne Capital Partenaires.